DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Suh KJ, Lee JY, Shin D-Y. et al.
Analysis of adverse events associated with Dasatinib and nilotinib treatments in chronic-phase chronic myeloid leukemia patients outside clinical trials.
Int J Hematol 2017;
106 (02) 229-239
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.